Intrexon (XON) Reports Q1 Loss Per Share of 55c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall St set to open higher as chips recover, megacap earnings loom
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Wall St set to open higher as chips recover, megacap earnings loom
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- IREN raises 2026 revenue target to $4bn after $2.8bn in contracts
- AMC Entertainment (AMC) Tops Q2 EPS by 16c
Intrexon Announces First Quarter 2016 Financial Results
May 10, 2016 4:08 PM EDTGERMANTOWN, Md., May 10, 2016 /PRNewswire/ --Â Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its first quarter results for 2016.Â
Business Highlights and Recent Developments:
National Health Surveillance Agency of Brazil (Anvisa) announced that Oxitec, a wholly-owned subsidiary of Intrexon, would receive a special temporary registration to deploy its genetically engineered mosquito, OX513A, known as 'Friendly Aedes aegypti', throughout the country;Â The World Health... More